Quantcast

Latest Dana-Farber Cancer Institute Stories

2010-11-03 06:00:00

NEWTON, Mass., Nov. 3, 2010 /PRNewswire/ -- Karyopharm Therapeutics Inc., a leader in the new field of nuclear transport modulators, has completed a $20M Series A financing. The nuclear transport machinery plays an integral role in the regulation of many molecules involved in a broad spectrum of human and animal disease. Karyopharm is focused on the discovery and development of novel selective inhibitors of nuclear export (SINE) for the treatment of cancer, autoimmune diseases and HIV....

2010-10-28 13:52:57

Patient's response was predicted by test for mutant protein in tumor cells A new oral drug caused dramatic shrinkage of a patient's rare, aggressive form of soft-tissue cancer that was driven by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute report in the Oct. 28 issue of the New England Journal of Medicine. A second patient who had a similar tumor that was not fueled by the mutant protein, called ALK (named for the first disease in which it was found,...

2010-10-26 12:00:00

NEW YORK, Oct. 26 /PRNewswire/ -- Signal Genetics, the parent company of Myeloma Health, a privately held predictive genetic testing company focused on oncology, today announced the formation of their Scientific Advisory Board. They include: Kenneth Anderson, M.D. Director, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute Kraft Family Professor of Medicine, Harvard Medical School Dr. Anderson of Dana-Farber Cancer Institute and Harvard Medical School holds the title of...

2010-10-22 18:58:09

Compared to adult patients, parents felt less informed about protocols Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23. Parents who had agreed to their...

2010-10-22 18:53:05

People treated for cancer when they were children have a higher-than-average risk of gastrointestinal problems "“ some mild, some quite severe "“ in the years following treatment, according to a study to be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Sunday, Oct. 24. Investigators at Dana-Farber/Children's Hospital Cancer Center and their colleagues say their findings suggest that childhood cancer survivors and their...

2010-10-22 08:45:00

Researchers to discuss their stimulus-funded project at Boston conference BOSTON, Oct. 22 /PRNewswire-USNewswire/ -- The National Institutes of Health has awarded a three-year, $3.9 million grant to Children's Hospital Boston researchers and their colleagues to develop a therapy to treat Fanconi anemia, a fatal genetic blood disease. The researchers will investigate new ways to create induced pluripotent stem (iPS) cells from a patient's skin or other tissue and transform them into...

2010-10-20 19:34:09

Research findings could change current practice Researchers from Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) have found that as many as 50 percent of young girls treated for germ-cell ovarian tumors might safely be spared chemotherapy using a "watch and wait" strategy to determine if the follow-up treatment is needed. In contrast to the current practice of administering chemotherapy to all patients following removal of these rare tumors, researchers said the study demonstrated...

2010-10-18 09:40:00

QUINCY, Mass., Oct. 18 /PRNewswire/ -- Stop & Shop today announced it received the 2010 Sidney Farber Medical Research Award, Dana-Farber Cancer Institute's highest accolade, for its 20-year partnership, that has raised more than $50 million for Dana-Farber and the Jimmy Fund, through Stop & Shop's annual Triple Winner Game. (Photo: http://photos.prnewswire.com/prnh/20101018/NY83593-a ) (Photo: http://www.newscom.com/cgi-bin/prnh/20101018/NY83593-a ) (Photo:...

2010-10-01 10:27:00

BOSTON, Oct. 1 /PRNewswire/ -- Two local institutions serving children's medical needs are about to benefit from Hess Corporation's home run program with the Boston Red Sox. Children's Hospital Boston's Trauma Program and the Jimmy Fund through the Red Sox Foundation each will receive a $55,000 check from Hess Retail Territory Manager Terri Bean at an on-field presentation at the Red Sox game on October 1. Hess Corporation promised to alternate $500 donations to the two institutions...

2010-09-25 02:04:49

In the quest to arrest the growth and spread of tumors, there have been many attempts to get cancer genes to ignore their internal instruction manual. In a new study, a team led by Dana-Farber Cancer Institute scientists has created the first molecule able to prevent cancer genes from "hearing" those instructions, stifling the cancer process at its root. The study, published online by the journal Nature, demonstrates that proteins issuing stop and start commands to a cancer gene "“...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related